Sorrento Therapeutics
SRNEQ
$0.03000
Share price
3.45%
Change (1 day)
-85.00%
Change (1 year)
Categories
Sorrento Therapeutics (SRNEQ) - Total liabilities
Total liabilities on the balance sheet as of June 2023 : $0.65 B
According to Sorrento Therapeutics 's latest financial reports the company's total liabilities are $0.65 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Sorrento Therapeutics - Total liabilities on balance sheet (from 2004 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $0.49 B | -19.81% |
| 2021-12-31 | $0.61 B | 56.09% |
| 2020-12-31 | $0.39 B | -24.73% |
| 2019-12-31 | $0.52 B | 25.99% |
| 2018-12-31 | $0.41 B | 85.15% |
| 2017-12-31 | $0.22 B | -28.59% |
| 2016-12-31 | $0.31 B | 55.53% |
| 2015-12-31 | $0.20 B | 517.1% |
| 2014-12-31 | $32.82 M | 27.37% |
| 2013-12-31 | $25.77 M | 4311.88% |
| 2012-12-31 | $0.58 M | 62.57% |
| 2011-12-31 | $0.35 M | -40.5% |
| 2010-12-31 | $0.6 M | 71.06% |
| 2009-12-31 | $0.35 M | 200.62% |
| 2008-12-31 | $0.11 M | 3475.28% |
| 2007-12-31 | $0 M | -99.3% |
| 2006-12-31 | $0.47 M | 1351.65% |
| 2005-12-31 | $0.03 M | -90.46% |
| 2004-12-31 | $0.34 M | 0.22% |
| 2003-12-31 | $0.33 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Karyopharm Therapeutics
KPTI | $0.37 B | -42.47% | 🇺🇸 USA |
 Exelixis EXEL | $0.67 B | 3.22% | 🇺🇸 USA |